Clinical-radiomics signature predicts pathologic complete response after neoadjuvant therapy in esophageal squamous cell carcinoma
{{output}}
Objectives: Neoadjuvant therapy (NAT) significantly improves the pathologic complete response (pCR) rates in patients with locally advanced oesophageal squamous cell carcinoma (ESCC). Emerging evidence suggests that patients with... ...
